about
Expert team yields high quality results
Able Biolabs is led by a team of PhD and MD-level scientists and seasoned industry professionals. Our non-GLP facilities are fully staffed and equipped to support your research projects. For specialized analyses and GLP work, we have relationships with partners such as SRI (a non-profit research institute founded by Stanford University). Our relationship with the University of Alabama at Birmingham also allows us to draw on expert advisory support on an as-needed basis.
Able Biolabs is led by a team of PhD and MD-level scientists and seasoned industry professionals. Our non-GLP facilities are fully staffed and equipped to support your research projects. For specialized analyses and GLP work, we have relationships with partners such as SRI (a non-profit research institute founded by Stanford University). Our relationship with the University of Alabama at Birmingham also allows us to draw on expert advisory support on an as-needed basis.
What we offer
In vitro and ex vivo models
We leverage traditional cell-based models as well as ex vivo approaches such as air-liquid interface and organoids to support your initial proof of concept work.
In vivo models
Our team has deep experience with a variety of small animals (mice, rats, ferrets) and models ranging from respiratory to oncology. Drug assets can be tested for therapeutic or preventive activity using any route of administration.
Custom models
For models that are not “out of the box” (ie. rare diseases), we offer support in developing and validating protocols. Transparency in collaboration is a core value and our teams will work together to design a solution to fit your needs.
In vitro and ex vivo models
We leverage traditional cell-based models as well as ex vivo approaches such as air-liquid interface and organoids to support your initial proof of concept work.
In vivo models
Our team has deep experience with a variety of small animals (mice, rats, ferrets) and models ranging from respiratory to oncology. Drug assets can be tested for therapeutic or preventive activity using any route of administration.
Custom models
For models that are not “out of the box” (ie. rare diseases), we offer support in developing and validating protocols. Transparency in collaboration is a core value and our teams will work together to design a solution to fit your needs.
What we offer
In vitro and ex vivo models
We leverage traditional cell-based models as well as ex vivo approaches such as air-liquid interface and organoids to support your initial proof of concept work.
In vivo models
Our team has deep experience with a variety of small animals (mice, rats, ferrets) and models ranging from respiratory to oncology. Drug assets can be tested for therapeutic or preventive activity using any route of administration.
Custom models
For models that are not “out of the box” (ie. rare diseases), we offer support in developing and validating protocols. Transparency in collaboration is a core value and our teams will work together to design a solution to fit your needs.
In vitro and ex vivo models
We leverage traditional cell-based models as well as ex vivo approaches such as air-liquid interface and organoids to support your initial proof of concept work.
In vivo models
Our team has deep experience with a variety of small animals (mice, rats, ferrets) and models ranging from respiratory to oncology. Drug assets can be tested for therapeutic or preventive activity using any route of administration.
Custom models
For models that are not “out of the box” (ie. rare diseases), we offer support in developing and validating protocols. Transparency in collaboration is a core value and our teams will work together to design a solution to fit your needs.
LATEST NEWS
ABLE BIOLABS EXPANDS PRECLINICAL SERVICES WITH SRI
Able Biolabs will work with SRI to expand each company’s preclinical services portfolio for its biotech and biopharma clients. This collaboration leverages the expertise of each organization to drive new business opportunities and advance preclinical research.
Your trusted partner in preclinical services
